These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7757959)

  • 21. Assessment of anti-estrogenic activity of tamoxifen in transgenic mice expressing an enhanced green fluorescent protein gene regulated by estrogen response element.
    Hayashi Y; Toda K; Saibara T; Okada T; Enzan H
    Biochim Biophys Acta; 2006 Feb; 1760(2):164-71. PubMed ID: 16309844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a point mutation in the hormone binding domain of the estrogen receptor from an breast tumor.
    England GM; Bilimoria MM; Chen Z; Assikis VJ; Muenzner HD; Jordan VC
    Int J Oncol; 1998 May; 12(5):981-6. PubMed ID: 9538117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.
    Zhang CC; Krieg S; Shapiro DJ
    Mol Endocrinol; 1999 Apr; 13(4):632-43. PubMed ID: 10194768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.
    Webb P; Lopez GN; Uht RM; Kushner PJ
    Mol Endocrinol; 1995 Apr; 9(4):443-56. PubMed ID: 7659088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A molecular strategy to control tamoxifen resistant breast cancer.
    Jiang SY; Jordan VC
    Cancer Surv; 1992; 14():55-70. PubMed ID: 1423331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells.
    Catherino WH; Jordan VC
    Cancer Lett; 1995 Mar; 90(1):35-42. PubMed ID: 7720041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture.
    Swiatecka J; Dziecioł J; Anchim T; Dabrowska M; Pietruczuk M; Wołczyński S
    Neoplasma; 2000; 47(1):15-24. PubMed ID: 10870682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts.
    Sasaki-Iwaoka H; Maruyama K; Endoh H; Komori T; Kato S; Kawashima H
    J Bone Miner Res; 1999 Feb; 14(2):248-55. PubMed ID: 9933479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
    Planas-Silva MD; Waltz PK; Kilker RL
    J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):193-8. PubMed ID: 16464573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The promoter of the rat 3-hydroxy-3-methylglutaryl coenzyme A reductase gene contains a tissue-specific estrogen-responsive region.
    Di Croce L; Vicent GP; Pecci A; Bruscalupi G; Trentalance A; Beato M
    Mol Endocrinol; 1999 Aug; 13(8):1225-36. PubMed ID: 10446899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Hydroxytamoxifen differentially exerts estrogenic and antiestrogenic effects on discrete subpopulations of human breast cancer cells.
    Willard ST; Abrahman EJ; Faught WJ; Leaumont DC; Frawley LS
    Endocrine; 2001 Mar; 14(2):247-52. PubMed ID: 11394643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rat endometrial adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivo/in vitro tumor model.
    Vollmer G; Schneider MR
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):103-15. PubMed ID: 8809192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.
    Fujimoto N; Katzenellenbogen BS
    Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?
    Lau CB; Ho TC; Chan TW; Kim SC
    Menopause; 2005; 12(6):734-40. PubMed ID: 16278617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene.
    Byrne IM; Flanagan L; Tenniswood MP; Welsh J
    Endocrinology; 2000 Aug; 141(8):2829-36. PubMed ID: 10919269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
    Jeng MH; Parker CJ; Jordan VC
    Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen.
    Boyan BD; Sylvia VL; Frambach T; Lohmann CH; Dietl J; Dean DD; Schwartz Z
    Endocrinology; 2003 May; 144(5):1812-24. PubMed ID: 12697687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.